These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4960848)

  • 21. Experience with cycloserine.
    Dissmann E
    Scand J Respir Dis Suppl; 1970; 71():239-43. PubMed ID: 5317744
    [No Abstract]   [Full Text] [Related]  

  • 22. Results of treatment of patients with pulmonary tuberculous with a combination of cycloserine and other tuberculostatics.
    Raboukhine A
    Scand J Respir Dis Suppl; 1970; 71():155-8. PubMed ID: 5271977
    [No Abstract]   [Full Text] [Related]  

  • 23. [The problem of infectiousness of tuberculosis patients during chemotherapy].
    Schulthess HK; Zollikofer H
    Schweiz Med Wochenschr; 1981 Feb; 111(8):251-4. PubMed ID: 6785880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and laboratory experiences with cycloserine.
    Jancík E; Boucková I; Janciková M; Novák M
    Scand J Respir Dis Suppl; 1970; 71():306-13. PubMed ID: 5272001
    [No Abstract]   [Full Text] [Related]  

  • 25. [Concentration of ethionamide and cycloserine in the blood of the patients with pulmonary tuberculosis].
    Ivanova ES
    Antibiotiki; 1967 Aug; 12(8):727-32. PubMed ID: 4968419
    [No Abstract]   [Full Text] [Related]  

  • 26. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug dependance of Mycobacterium tuberculosis].
    Mel'nikov EL
    Probl Tuberk; 1969; 47(5):60-4. PubMed ID: 4983819
    [No Abstract]   [Full Text] [Related]  

  • 28. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical efficiency of cycloserine in association with other tuberculostatics.
    Anastasatu C; Ulpian C; Weiss P
    Scand J Respir Dis Suppl; 1970; 71():152-4. PubMed ID: 5271976
    [No Abstract]   [Full Text] [Related]  

  • 30. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
    Gorokhova TV
    Probl Tuberk; 1997; (2):33-5. PubMed ID: 9235582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On the drug resistance of Myc. tuberculosis isolated from patients with primary pulmonary tuberculosis. Bacteriological and clinical observations].
    ZORZOLI P; MONCALVO F
    G Ital Tuberc Mal Torace; 1962; 16():219-passim. PubMed ID: 14003952
    [No Abstract]   [Full Text] [Related]  

  • 33. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug resistance of Mycobacterium tuberculosis during the cycloserine treatment of pulmonary tuberculosis patients].
    STEPANIAN ES; SERGEEV VV
    Probl Tuberk; 1962; 40(8)():84-7. PubMed ID: 13983851
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the effect of cycloserine and kanamycin on Mycobacterium tuberculosis (bacteriological and electron microscopic study)].
    Chertkova EI
    Probl Tuberk; 1965; 43(9):57-62. PubMed ID: 4958492
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H; Takahashi R; Nakai T; Torii R; Yo I
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K; Kudo S; Iwai K; Ushikubo K
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.